Indaptus Therapeutics, Inc.
USD3.06
-0.35 (-10.26%)
CEO
Junyi Dai
IPO Date
2015-08-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.41
Prev. Close
$3.41
Day Low
$2.99
Day High
$3.59
52W Low
$0.92
52W High
$13.40
Market Cap
$0.01B
Volume
0.22M
| $0.00 |
| 2 Apr 2026 | SINO LION VENTURES Ltd | 10 percent owner | Disposed | 0 | $0.00 |
| 2 Apr 2026 | Dai Junyi | Chief Executive Officer | Disposed | 0 | $0.00 |
| 24 Mar 2026 | Lazar David E. | director | S-Sale | Disposed | 196,800 | $0.00 |
| 24 Mar 2026 | Lazar David E. | director | S-Sale | Disposed | 700,000 | $0.00 |
| 27 Feb 2026 | Jabbour Jerome D | director | A-Award | Acquired | 25,000 | $2.06 |
| 27 Feb 2026 | Jabbour Jerome D | director: | Disposed | 0 | $0.00 |
| 26 Feb 2026 | McMurdo Matthew Charles | director | Disposed | 0 | $0.00 |
| 13 Feb 2026 | Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | D-Return | Disposed | 3,033 | $47.60 |